Ja. Kim et Mj. Druse, PROTECTIVE EFFECTS OF MATERNAL BUSPIRONE TREATMENT ON SEROTONIN REUPTAKE SITES IN ETHANOL-EXPOSED OFFSPRING, Developmental brain research, 92(2), 1996, pp. 190-198
Previous work in this laboratory demonstrated that in utero ethanol ex
posure is associated with abnormal development of the serotonergic sys
tem. Specific abnormalities included deficiencies of serotonin (5-HT)
and its metabolites, and cortical 5-HT reuptake sites. The concentrati
on of 5-HT1A receptors was also altered. The serotonin deficit was det
ected in the fetal ethanol-exposed brain, at an age when 5-HT would no
rmally function as an essential trophic factor. Thus, it was hypothesi
zed that the early 5-HT ethanol-associated deficit of an essential tro
phic factor (e.g. 5-HT) could contribute to subsequent developmental a
bnormalities in serotonergic neurons. In the present investigation we
used quantitative autoradiography (QAR) to more fully characterize the
developmental abnormalities in 5-HT reuptake sites in developing offs
pring of ethanol-fed rats. In addition, we attempted to overcome the p
otential negative impact of the ethanol-associated deficit of fetal 5-
HT, by administering a 5-HT1A agonist, buspirone, to pregnant rats. Th
ese investigations demonstrated that postnatal (PN) 19 and/or 35 day e
thanol-exposed offspring had a significant decrease in [H-3]citalopram
binding to 5-HT reuptake sites in the frontal cortex, parietal cortex
, lateral hypothalamus, substantia nigra, medial septum, and striatum.
In contrast, [H-3]citalopram binding was increased in the dorsal raph
e on PN5 and in the median raphe on PN19. No significant ethanol-assoc
iated changes were detected in the hippocampus CA3 region or in the am
ygdala. When [H-3]citalopram binding was compared in the offspring of
saline- and buspirone-treated dams, it appeared that maternal treatmen
t with buspirone prevented or reversed most of the ethanol-associated
developmental abnormalities in 5-HT reuptake sites. Buspirone prevente
d the decline in binding of [H-3]citalopram in the frontal cortex, lat
eral hypothalamus, substantia nigra and medial septum. Similarly, busp
irone treatment prevented the ethanol-associated increase in binding i
n the dorsal and median raphe. Additional experiments are needed to el
ucidate the impact of maternal buspirone treatment on the development
of other neurotransmitter systems in offspring.